| Product Code: ETC7635775 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Ireland`s octreotide import market saw significant growth in 2024, with top exporting countries being Sweden, China, USA, Netherlands, and Switzerland. The market concentration, as measured by the HHI, remained very high, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was a robust 19.82%, with a notable growth rate of 28.21% in 2024 alone. This data suggests a strong demand for octreotide in Ireland and highlights the country`s reliance on these key exporting nations for their supply.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Octreotide Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Octreotide Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Octreotide Market - Industry Life Cycle |
3.4 Ireland Octreotide Market - Porter's Five Forces |
3.5 Ireland Octreotide Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Octreotide Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 Ireland Octreotide Market Revenues & Volume Share, By Indications, 2021 & 2031F |
3.8 Ireland Octreotide Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Ireland Octreotide Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Octreotide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases such as acromegaly and neuroendocrine tumors that require octreotide treatment |
4.2.2 Growing awareness about the benefits of octreotide therapy among healthcare professionals and patients |
4.2.3 Technological advancements leading to the development of more effective and targeted octreotide formulations |
4.3 Market Restraints |
4.3.1 High treatment costs associated with octreotide therapy |
4.3.2 Stringent regulatory requirements for the approval and marketing of octreotide products |
4.3.3 Limited availability of skilled healthcare professionals for administering octreotide therapy |
5 Ireland Octreotide Market Trends |
6 Ireland Octreotide Market, By Types |
6.1 Ireland Octreotide Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Octreotide Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Octreotide Market Revenues & Volume, By octreotide acetate, 2021- 2031F |
6.1.4 Ireland Octreotide Market Revenues & Volume, By octreotide, 2021- 2031F |
6.1.5 Ireland Octreotide Market Revenues & Volume, By octreotide chloride, 2021- 2031F |
6.1.6 Ireland Octreotide Market Revenues & Volume, By octreotide hydrochloride, 2021- 2031F |
6.1.7 Ireland Octreotide Market Revenues & Volume, By indium In-111; octreotide, 2021- 2031F |
6.2 Ireland Octreotide Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Ireland Octreotide Market Revenues & Volume, By Injection, 2021- 2031F |
6.2.3 Ireland Octreotide Market Revenues & Volume, By Powder, 2021- 2031F |
6.2.4 Ireland Octreotide Market Revenues & Volume, By Microspheres, 2021- 2031F |
6.3 Ireland Octreotide Market, By Indications |
6.3.1 Overview and Analysis |
6.3.2 Ireland Octreotide Market Revenues & Volume, By Diarrhoea, 2021- 2031F |
6.3.3 Ireland Octreotide Market Revenues & Volume, By Acromegaly, 2021- 2031F |
6.3.4 Ireland Octreotide Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Octreotide Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Octreotide Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ireland Octreotide Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Ireland Octreotide Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Ireland Octreotide Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Octreotide Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Octreotide Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Ireland Octreotide Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Ireland Octreotide Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Ireland Octreotide Market Import-Export Trade Statistics |
7.1 Ireland Octreotide Market Export to Major Countries |
7.2 Ireland Octreotide Market Imports from Major Countries |
8 Ireland Octreotide Market Key Performance Indicators |
8.1 Patient adherence rate to octreotide treatment plans |
8.2 Number of clinical trials evaluating the efficacy of new octreotide formulations |
8.3 Rate of adoption of octreotide therapy in different healthcare facilities |
9 Ireland Octreotide Market - Opportunity Assessment |
9.1 Ireland Octreotide Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Octreotide Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 Ireland Octreotide Market Opportunity Assessment, By Indications, 2021 & 2031F |
9.4 Ireland Octreotide Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Ireland Octreotide Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Octreotide Market - Competitive Landscape |
10.1 Ireland Octreotide Market Revenue Share, By Companies, 2024 |
10.2 Ireland Octreotide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here